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Idiopathic pulmonary ﬁbrosis (IPF) is often associated with exercise-induced hypoxemia.
Although maximal oxygen consumption (VO2(max)) is considered the gold-standard index of
functional capacity in IPF, its measurement requires sophisticated equipment and trained
personnel. The aim of the present study was to investigate the value of the simple 15-steps
climbing exercise oximetry test in patients with IPF.
The 15-steps climbing test was administered to 51 patients with IPF. Pulmonary function
tests (PFTs), cardiopulmonary exercise test (CPET), and the 6-min walk distance (6MWD)
test were performed in the same session. Oxygen saturation in the 15-steps climbing test
was measured by continuous oximetry, and quantiﬁed oxygen desaturation was determined
by calculating the area under the curve of oxygen saturation from the beginning of
exercise through the lowest desaturation point until recovery to baseline (‘‘desaturation
area’’).
There was a statistically signiﬁcant correlation between all parameters of the 15-steps
climbing test and both VO2(max) on the CPET (lowest saturation, p ¼ 0.002, r ¼ 0.43;
saturation difference, p ¼ 0.02, r ¼ 0.33; recovery time, p ¼ 0.02, r ¼ 0.32; and
desaturation area, p ¼ 0.005, r ¼ 0.39), and carbon dioxide diffusion in the lungs (DLCO)
on the PFTs (lowest saturation, p ¼ 0.0001, r ¼ 0.52; saturation difference, p ¼ 0.0002,
r ¼ 0.50; recovery time, p ¼ 0.0001, r ¼ 0.53; and desaturation area, p ¼ 0.0001,
r ¼ 0.53). On stepwise linear regression analysis, independent signiﬁcant predictors of
VO2(max) were lowest saturation on the 15-steps test and the 6MWD.Published by Elsevier Ltd.
onary ﬁbrosis; VO2(max), maximum volume of oxygen consumption; PFTs, pulmonary function tests;
ronic obstructive pulmonary disease; CPET, cardiopulmonary exercise test; MVV, maximal voluntary
iffusion capacity; SaO2, oxygen saturation.
nstitute, Rabin Medical Center, Beilinson Campus, Petah Tiqwa 49100, Israel. Tel.: +972 3 937 7221;
g.il (M.R. Kramer).
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15-Steps test in pulmonary ﬁbrosis 1081We concluded that the 15-steps oximetry test is a simple and accurate bedside tool for the
evaluation of functional capacity in patients with IPF.
& 2008 Published by Elsevier Ltd.Introduction
Pulmonary ﬁbrosis is a chronic lung disease causing
inﬂammation and scarring of the alveoli and interstitial
tissues of the lung.1 Some uncommon and rare diseases can
cause pulmonary ﬁbrosis, but in the majority of cases, the
cause is unknown.1,2 A central pathophysiologic feature of
idiopathic pulmonary ﬁbrosis (IPF) is impaired gas exchange
which worsens with exercise.1,2 The mechanisms underlying
the limited exercise capacity in IPF are complex and varied,
and include ventilatory limitation, diffusion impairment,
and ventilation–perfusion derangement.3,4 The presence of
exercise-induced hypoxemia serves as a predictor of survival
in patients with IPF.5,6 According to the recent statement of
the American Thoracic Society,1 even a 4% decrease in
saturation during exercise is an adverse prognostic sign.1
Therefore, the evaluation of hypoxia and functional capa-
city during exercise are an important part of patient
management.
Although maximal volume of oxygen consumption
(VO2(max)) is considered the gold-standard index of func-
tional capacity in IPF, its measurement requires sophisti-
cated equipment and trained personnel. Other tests
currently available include pulmonary function tests (PFTs),
and the 6-min walk distance (6MWD) test.7
The 15-steps climbing test oximetry has been found useful
for estimating ventilatory reserve in patients with chronic
obstructive pulmonary disease (COPD) and for predicting
postoperative complications of lung resection.8 A good
correlation has been found with PFTs.9,10 Several studies
have also found it effective for assessing arterial hypoxemia
and recommended its use as a marker of disease severity
and the need for oxygen supplementation.11–13
The aim of the present study was to assess the potential
value of the simple, objective 15-steps climbing test
for the evaluation of function of capacity in patients
with IPF.Patients and methods
Patients and setting
A prospective open study design was used. The study group
comprised 51 patients with IPF attending the Pulmonary
Institute of Rabin Medical Center, a tertiary hospital in
central Israel, during the 6-month period from April to
September 2006. Diagnoses were made according to the
criteria of the American Thoracic Society.1 Patients with
acute or chronic cardiac disease, exacerbation of COPD, or
other pulmonary or infective disease within 2 months
preceding the trial were excluded.
The study was approved by the Ethics Committee of Rabin
Medical Center.Procedure
The demographic, clinical, and laboratory data of the
patients were retrieved from the ﬁles. The 15-steps exercise
test was administered to all patients as part of their routine
follow-up evaluation. The PFTs were performed ﬁrst,
followed, on the same day, by the upright maximal
cardiopulmonary exercise test (CPET), the 6MWD test, and
the 15-steps climbing exercise test. The interval between
tests was at least 2 h. The order of the exercise tests was
randomized. All tests were performed according to the
American Thoracic Society guidelines.14–18Pulmonary function tests
The PFTs were performed according to the ATS/ERS guide-
lines14–16 with the Medical Graphics Pulmonary Function
System (1070-series 2, St. Paul, MN, USA). Lung volumes
were obtained by body plethysmography (model 1085,
Medical Graphics). Maximal voluntary ventilation (MVV)
was assessed by asking the patient to breathe as fast and
as deeply as possible for 12 s, and the result was multiplied
by 5. Carbon monoxide diffusion capacity (DLCO) was
measured with a gas mixture containing air, 10% helium,
and 0.3% carbon monoxide; each measurement was adjusted
to standard temperature and pressure. The predicted values
of the parameters were obtained from the regression
equations of the European Community for Coal and Steel.Cardiopulmonary exercise test
The CPETwas performed according to the ATS statement.17
The test was done between 8:30 a.m. and 12:00 noon.
Patients were encouraged to take their medications as
usual. An incremental exercise test was administered ﬁrst,
according to the protocol of Wasserman.29 On arrival at the
exercise laboratory, patients were connected to a 12-lead
electrocardiogram (Cardiofax, Nihon Kohden, Tokyo, Japan)
with a single-lead (v5) monitor (VC-22, Nihon Kohden).
Oxygen saturation (SaO2) was measured by pulse oximetry
(Nellcor NPB-190, Pleasanton, CA, USA), and blood pressure,
with a sphygmomanometer. The patient was then positioned
on an electrically braked cycle ergometer (Ergoline 800,
Bitz, Germany). After a 2-min rest (arms at sides), they were
asked to performed unloaded pedaling for 2min at a rate
of 60 rpm. The load was then progressively increased by
15W/min (ramp protocol). The duration of the test was
symptom-limited; the endpoint was deﬁned as the point at
which the patient could not maintain a pedaling rate of
more than 40 rpm.
Cardiopulmonary data were collected and analyzed with
an exercise metabolic unit (CPX, Medical Graphics). Heart
rate, minute ventilation (VE), tidal volume (VT), oxygen
consumption (VO2), carbon dioxide production (VCO2),
respiratory rate (RR), total ventilation (Vd/Vt), oxygen
pulse (O2P), and oxygen saturation (SaO2) were recorded
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Blood pressure was measured with a sphygmomanometer
at rest and every 2min until peak exercise. The dyspnea
index (VE/MVV), expressed in percent, was calculated
manually.6-min walk test
The 6MWD test was done according to the ATS guidelines.18
The test was performed along a measured indoor corridor in
our institute. Participants were encouraged to cover as
much distance as possible.15-steps climbing exercise oximetry test
A ﬁnger oximeter (8500, Nonin Medical, Plymouth, MN, USA)
for continuous online recording of pulse rate and oxygen
saturation was connected to each patient. The data were
sampled every 2 s, and the mean value was recorded every
10 s. A step measuring 25 cm length by 50 cm width by 20 cm
height was used; patients were asked to climb up and down
the step 15 times as fast as they could, without any ﬁxed
pacing. Each test was repeated twice, and the mean
oximeter values were recorded. When oximeter readings
were not optimal, as detected by a yellow or red signal, the
data were discarded. The exercise time was recorded, as
was the time from the start of exercise to lowest saturation
(desaturation time), and the time from lowest saturation to
recovery to baseline (recovery time), Figure 1. The total
test time was deﬁned as the time from the start of exercise
to complete recovery (sum of desaturation and recovery
times). Baseline oxygen saturation, lowest saturation, and
highest pulse were recorded. We also calculated the
triangular area under the oxygen saturation curve between
baseline and 98% saturation during the whole maneuver
(‘‘desaturation area’’) [(baseline SaO2lowest SaO2) 0.5
test time+(98%-baseline SaO2) test time], Figure 1.Tim
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Figure 1 The mean oxygen saturations of the study population dur
idiopathic pulmonary ﬁbrosis (n ¼ 51).Statistical analysis
Results are shown as mean7standard deviation. Pearson
correlation coefﬁcient (r) and the signiﬁcance for it (p) were
calculated between the variables. To analyze differences in
the **distribution of categorical data, w2 test or Fisher exact
test was used, as appropriate. The data were ﬁtted to a
logistic regression model to identify predictors of VO2(max)
and DLCO. Odds ratios and 95% conﬁdence intervals were
calculated from the model.
A p-value of 0.05 or less was considered statistically
signiﬁcant.Results
Demographic data
All 51 patients completed the PFTs and the three exercise
tests: CPET, 6MWD test, and 15-steps oximetry test.
Table 1 summarizes the demographic and clinical data.
Twenty-nine patients were male. Mean age was 58711
years (range 17–80 years). Twenty-four patients were
nonsmokers, 25 had smoked in the past, and 2 continued
to smoke during the study period. Most of the patients (94%)
had NYHA functional class II–IV. Twenty patients (39%)
were on the waiting list for lung transplantation. Twenty-
ﬁve (50%) patients were being treated with oxygen
supplementation.Pulmonary function tests
The results of the PFTs are shown in Table 2. The majority of
patients had severe restrictive and perfusion abnormalities.
Mean forced expiratory volume in 1 s (FEV1) was 61721% of
predicted (range 23–130%); mean forced volume capacitye (sec)
30027024021018050
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Table 1 Demographic and clinical data of the study
population (n ¼ 51).
Variables
Age, year (mean7S.D.) 58711
Male-to-female ratio 29:22
Smoking history
Past 25 (50)
Current 2 (4)
Non-smoker 24 (47)
NYHA functional class
I 3 (6)
II 18 (35)
III 20 (39)
IV 10 (20)
Diagnosis biopsy
Yes 33 (65)
No 18 (35)
Treatment for IPF
In the past 1 (2)
Current treatment 42 (82)
No 8 (16)
Oxygen supplementation
Yes 25 (49)
No 26 (51)
IPF, idiopathic pulmonary ﬁbrosis; NYHA, New York heart
association.
All data except age are given as number (%).
Table 2 Pulmonary lung functions of the study popula-
tion (n ¼ 51).
Resting pulmonary function parameters Value
FEV1, % pred 61721
FVC, % pred 6272
TLC, % pred 65715
RV, % pred 89725
DLCO, % pred 36714
DLCO, diffusion capacity of monoxide carbon; FEV1, forced
expiratory volume at 1 s; FVC, forced volume capacity; RV,
residual volume; TLC, total lung capacity.
Table 3 Results of cardiopulmonary exercise test, 6-
min walk distance test and 15 steps climbing test in
patients with idiopathic pulmonary ﬁbrosis (n ¼ 51).
Parameters Data
Cardiopulmonary exercise test
VO2(max) (ml/kg/min) 1173
Ventilation (%) 43714
Breathing reserve (l/min) 25719
Respiratory rate (l/min) 47714
Vd/Vt (%) 3877
Saturation at the end of exercise (%) 8876
6-min walk distance test
Saturation at rest (%) 9473
Saturation after exercise (%) 8678
Saturation difference (%) 877
Distance (m) 397798
15-steps climbing test
Saturation baseline (%) 9573
Saturation lowest (%) 8677
Saturation difference (%) 975
Exercise time (s) 52712
Desaturation time (s) 74721
Recovery time (s) 78744
Desaturation area (s %) 131471078
15-Steps test in pulmonary ﬁbrosis 1083was 60720% of predicted (range 23–112%); and mean total
lung capacity was 65715% of predicted (range 39–77%).
Mean DLCO was 36714% of predicted (range 8–77%).Exercise tests
Table 3 summarizes the results of the three exercise tests.
Mean VO2(max) on the CPET was 1173ml/kg/min (range
5.7–23.5); mean breathing reserve was 25719 l (range
2–99 l), and mean saturation at the end of exercise was
8876% (range 73–95%). The mean 6MWD was 397798m(range 180–613m); mean post-exercise saturation was
8678% (range 61–97%), and the mean difference between
saturation at rest and post-exercise saturation was 877%
(range 0–38%).
In the 15-steps test, mean lowest saturation was 8677%
(range 70–99), mean difference at rest and lowest satura-
tion was 975% (range 0–19), mean desaturation time was
74721 s (range 0–120), mean recovery time was 78744 s
(range 0–220 s), mean desaturation area was 131471078 s %
(range 0–4200 s %).
Correlation analysis
Table 4 and Figures 2 and 3 presents the correlations
between the parameters of the 15-steps oximetry test and
the CPET, PFTs, and 6MWD.
Correlation between 15-steps oximetry test and CPET
Statistically signiﬁcant correlations were noted between
VO2(max) and all 15-steps climbing test parameters: lowest
saturation, p ¼ 0.002, r ¼ 0.43; saturation difference,
p ¼ 0.02, r ¼ 0.33; recovery time, p ¼ 0.02, r ¼ 0.32;
and desaturation area, p ¼ 0.005, r ¼ 0.39. Other para-
meters from the CPET were also correlated with 15-steps
test parameters (Table 4).
Correlation between 15-steps oximetry test and PFTs
Good correlations were noted between DLCO and the
climbing test parameters; lowest saturation, p ¼ 0.0001,
r ¼ 0.52; saturation difference, p ¼ 0.0002, r ¼ 0.50;
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area, p ¼ 0.0001, r ¼ 0.53. Total lung capacity also
correlated with 15-steps test recovery time and desatura-
tion area (Table 4).Correlation between 15-steps oximetry test and 6MWD
Post-exercise saturation on the 6MWD test strongly corre-
lated with all 15-steps parameters: lowest saturation,
p ¼ 0.0001, r ¼ 0.94; saturation difference, p ¼ 0.0001,
r ¼ 0.88; recovery time, p ¼ 0.0001, r ¼ 0.60; andTable 4 Correlation of 15-steps oximetry test with cardiopulm
walk test.
15-Steps climbing parameters
Sat. baseline Sat. lowest Sat. difference Exercis
CPET
VO2(max)
r 0.45 0.43 0.33 0.34
p 0.0009 0.002 0.02 0.01
Vent.
r 0.21 0.08 0.03 0.41
p 0.14 0.58 0.85 0.003
Breath res
r 0.15 0.14 0.10 0.26
p 0.3000 0.3357 0.4658 0.070
RR
r 0.22 0.38 0.42 0.02
p 0.1173 0.0061 0.0022 0.901
Vd/Vt
r 0.47 0.51 0.44 0.30
p 0.0005 0.0002 0.0014 0.034
Sat end-ex
r 0.69 0.85 0.80 0.07
p o0.0001 o0.0001 o0.0001 0.610
PFTs
FVC
r 0.34 0.25 0.14 0.01
p 0.0138 0.0725 0.3140 0.928
FEV1
r 0.36 0.21 0.07 0.04
p 0.0091 0.1303 0.6154 0.756
TLC
r 0.37 0.36 0.29 0.01
p 0.0072 0.0088 0.0402 0.924
RV
r 0.05 0.03 0.02 0.06
p 0.7156 0.8082 0.9103 0.659
DLCO
r 0.41 0.52 0.50 0.11
p 0.0031 0.0001 0.0002 0.439
6MWD test
Sat at rest
r 0.90 0.84 0.64 0.09
p o0.0001 o0.0001 o0.0001 0.516
Sat post ex
r 0.76 0.94 0.88 0.02
p o0.0001 o0.0001 o0.0001 0.884desaturation area, p ¼ 0.0001, r ¼ 0.9. Good correlations
were also noted between the 6MWD and exercise time
(p ¼ 0.0003, r ¼ 0.49) and desaturation area in the 15-steps
test.Correlations between VO2(max) and DLCO with all three
exercise tests
Table 5 summarizes the correlations of VO2(max) with the
other exercise tests performed, and of DLCO with all three
exercise tests. The 15-steps climbing test demonstratedonary exercise test, pulmonary function tests, and 6-minute
e time Desaturation time Recovery time Desat. area
0.32 0.32 0.39
0.0219 0.0217 0.0050
0.13 0.06 0.02
0.36 0.67 0.89
0.28 0.18 0.18
3 0.0482 0.2038 0.2158
0.32 0.45 0.42
8 0.0236 0.0010 0.0025
0.46 0.40 0.50
2 0.0008 0.0040 0.0003
0.33 0.55 0.81
9 0.0195 o0.0001 o0.0001
0.15 0.23 0.25
1 0.3006 0.1102 0.0771
0.15 0.16 0.22
3 0.2901 0.2612 0.1275
0.23 0.29 0.35
1 0.1059 0.0369 0.0130
0.09 0.07 0.01
4 0.5392 0.6099 0.9551
0.38 0.53 0.53
0 0.0059 o0.0001 0.0001
0.40 0.41 0.76
7 0.0035 0.0029 o0.0001
0.39 0.60 0.91
8 0.0042 o0.0001 o0.0001
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Table 4 (continued )
15-Steps climbing parameters
Sat. baseline Sat. lowest Sat. difference Exercise time Desaturation time Recovery time Desat. area
Sat diff
r 0.55 0.80 0.82 0.02 0.33 0.54 0.81
p o0.0001 o0.0001 o0.0001 0.8766 0.0181 o0.0001 o0.0001
Distance
r 0.39 0.29 0.16 0.49 0.23 0.27 0.32
p 0.0049 0.0402 0.2479 0.0003 0.1075 0.0583 0.0217
Parameters of 15-steps climbing test: Sat. baseline: saturation before the test; Sat. lowest: lowest level of oxygen saturation during
the test; Sat. difference: difference between baseline and lowest saturation; Exercise time: time of the exercise; Desat. time:
desaturation time, time from start to lowest saturation; Recovery time: recovery time, time from lowest saturation to recovery to
baseline level; Desat. area: desaturation area, calculated triangular area between baseline saturation and 98% saturation during the
complete maneuver (baseline SaO2lowest SaO2) 0.5 test time+(98%-baseline SaO2) test time). Parameters of the cardiopulmonary
exercise test (CPET): VO2(max): maximum volume of oxygen utilization; Vent: ventilation; Breath res: breathing reserve; RR: respiratory
rate; Vd/Vt: total ventilation ratio; Sat. end ex: saturation at end of exercise. Parameters of pulmonary function tests (PFTR): FVC:
forced vital capacity; FEV1: forced expiratory volume in 1 s; TLC: total lung capacity; RV: respiratory volume; DLCO: carbon monoxide
diffusion in the lung. Parameters of the 6-min walk distance test (6MWD): Sat. at rest: saturation at rest, before the test; Sat. post ex:
saturation after exercise; Sat. diff: saturation difference, difference between rest and post-exercise saturation; Distance: walk
distance.
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Figure 2 The correlations between the desaturation area of the 15-steps oximetry test and the diffusion capacity of monoxide
carbon (DLCO), maximum volume of oxygen utilization (VO2(max)) and 6-min walk distance test (6MWD) in patients with idiopathic
pulmonary ﬁbrosis (n ¼ 51).
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Figure 3 The correlations between the lowest saturation of the 15-steps oximetry test and the diffusion capacity of monoxide
carbon (DLCO), maximum volume of oxygen utilization (VO2(max)) and 6-min walk distance test (6MWD) in patients with idiopathic
pulmonary ﬁbrosis (n ¼ 51).
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Table 5 Correlation of VO2(max) with exercise and
functional parameters.
Parameters r p
PFTs
FVC 0.39 0.005
FEV1 0.37 0.008
TLC 0.44 0.001
RV 0.33 0.02
DLCO 0.44 0.001
6MWD test
Saturation at rest 0.49 0.0002
Saturation post-exercise 0.39 0.004
Saturation difference 0.26 0.07
Distance 0.64 0.0001
15 steps test
Saturation baseline 0.45 0.0009
Saturation lowest 0.43 0.002
Saturation difference 0.32 0.02
Exercise time 0.34 0.01
Desaturation time 0.32 0.02
Recovery time 0.32 0.39
Desaturation area 0.02 0.005
FVC, forced vital capacity; FEV1, forced expiratory volume in
1 s; TLC, total lung capacity; RV, respiratory volume; DLCO,
carbon monoxide diffusion in the lung.
Table 6 Correlations of DLCO with exercise tests.
Parameters r p
Cardiopulmonary exercise test
VO2(max) 0.44 0.0012
Vent 0.33 0.0185
Breath res 0.35 0.0114
RR 0.49 0.0003
Sat end ex 0.58 o0.0001
6MWD test
Sat at rest 0.44 0.0011
Sat post ex 0.49 0.0003
Sat diff 0.38 0.0058
Distance 0.47 0.0004
15 steps test
Sat baseline 0.41 0.0031
Sat lowest 0.52 0.0001
Sat difference 0.50 0.0002
Exercise time 0.11 0.4390
Desat time 0.38 0.0059
Recov time 0.53 o0.0001
Desat area 0.53 o0.0001
V. Rusanov et al.1086good correlations, with VO2(max) similar to the 6MWD test
and with DLCO, similar to the CPET and the 6MWD test.
Multivariate analysis
To predict VO2(max), a stepwise linear regression model was
ﬁtted to the data. The only signiﬁcant predictor variables
identiﬁed were lowest saturation on the 15-steps test
(p ¼ 0.002) and the 6MWD (p ¼ 0.003), with odds ratios of
1.044 (95% CI 1.016–1.092) and 1.005 (95% CI 1.003–1.011),
respectively.
Discussion
Several protocols have been suggested to assess hypoxemia
during exercise in patients with IPF. PFTs are traditionally
used to evaluate patients with interstitial lung disease,
based on ﬁndings that survival in patients with pulmonary
ﬁbrosis depends on the forced vital capacity and DLCO.19,20
However, although resting PFTs provide invaluable prognos-
tic information, they do not measure the fall in oxygen
saturation during exercise or requirements of oxygen
supplementation (Table 6).21,22
The CPET remains the gold standard,7 providing the best
index of functional capacity and global oxygen transport
(VO2(max)). It can also estimate both cardiac and pulmonary
reserves not available from other modalities.23 However,
VO2(max) cannot be measured in patients with advanced
cardiac and lung disease,25,26 and use the CPET requires
complicated equipment and trained staff.17 In addition, theexercise test may be intimidating to the frail, elderly or
severely disabled because the rate of exercise is not under
the patient’s control.
The most common alternative methods used today are
bicycle ergometry with different protocols, the 6MWD test,
and stair climbing. Each assesses the parameters differently,
namely, lowest arterial oxygen pressure (SaO2) achieved,
mean partial arterial oxygen (PaO2) or SaO2 during exercise,
and maximal drop in PaO2 or SaO2 from baseline.
The 6MWD test is simple, inexpensive and convenient; it
requires minimal medical personnel and can be performed in
an ofﬁce setting.18
It has excellent reproducibility, whereas maximal exercise
variables do not.24 The 6MWD test provides more accurate
prognostic information than resting PFTs in patients with
COPD,27,28 with good correlation with cardiopulmonary
exercise parameters (VO2(max) and peak PaO2).
29,30 It was
also found to be more sensitive than maximal incremental
cycle testing in detecting desaturation during exercise.31 In
patients with IPF, a highly signiﬁcant correlation was reported
between the 6MWD test, DLCO and VO2(max)
32,33 Moreover,
the amplitude of desaturation during the 6MWD was the
single strongest predictor of mortality.32,33 Some researchers
suggested that the test may be regarded as a surrogate
marker for VO2 in patients with IPF.
32,33 The 6MWD test has
also been recommended for patient assessment for listing for
lung transplantation.33 However, like the CPET, it may not be
used in patients with advanced lung disease.
The stair-climbing test is a very simple test, used for
the assessment of exercise capacity in patients with severe
lung disease. The test is simple, inexpensive and conveni-
ent. In contrast, the 6MWD test may not be used in patients
with advanced lung disease and required more compliance
from the patients. The stair-climbing test used for the
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15-Steps test in pulmonary ﬁbrosis 1087assessment of exercise capacity in patients with severe lung
disease.
In patients with COPD, it can be applied to effectively
estimate ventilatory reserve,8 assess arterial hypoxemia, and
predict complications of lung resection.9 It is also recom-
mended for use in patients with COPD as a marker of disease
severity and of the need for oxygen supplementation.11
In the present study, we investigated the potential role of
the stair-climbing test for the assessment of exercise-
induced hypoxemia and functional capacity in patients with
IPF. We calculated the desaturation area, which takes into
account the baseline saturation as well as the severity of
desaturation and recovery to baseline, and compared it with
ﬁndings on the PFTs and two other exercise tests, the CPET
and 6MWD, performed in the same session. We noted a
good correlation between all oximetry parameters (lowest
saturation, saturation difference, recovery time and desa-
turation area) and both VO2(max) and DLCO. These ﬁndings
indicate that the desaturation measured by the 15-steps
oximetry test is comparable to the desaturation measured
by the CPET and the 6MWD test, making the 15-steps test a
reliable tool for monitoring disease progression in IPF and
for evaluating the need for oxygen supplementation. The
test may serve as a surrogate marker of VO2(max) and an
alternative to the 6MWD test in this setting.
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